Associate Director, HCP Marketing

About PharmaEssentia

pharmaessentia.com

PharmaEssentia is a Taiwan-based global biopharmaceutical company focused on researching, developing, and commercializing best-in-class therapies for blood disorders and other serious diseases. Its portfolio includes Ropeginterferon alfa‑2b (marketed as Besremi) for polycythemia vera and other myeloproliferative neoplasms, and the company conducts clinical trials, medical affairs, and manufacturing activities worldwide. PharmaEssentia provides resources for patients and healthcare professionals and emphasizes innovation in protein engineering and biologics production. It aims to bring effective, scientifically driven treatments to patients through robust R&D and global partnerships.